Iron Gate Global Advisors’s AbbVie ABBV Stock Holding History

Iron Gate Global Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$325K	Buy	1,493 +63	+4%	+$14K	0.03%	73
2025 Q4	$327K	Buy	1,430 +17	+1%	+$3.87K	0.03%	71
2025 Q3	$328K	Buy	+1,413	New	+$288K	0.03%	75
2025 Q2	–	Sell	-1,160	Closed	-$243K	–	84
2025 Q1	$243K	Sell	1,160 -216	-16%	-$42K	0.03%	76
2024 Q4	$245K	Buy	1,376 +9	+0.7%	+$1.66K	0.03%	77
2024 Q3	$270K	Hold	1,367	–	–	0.04%	71
2024 Q2	$234K	Sell	1,367 -8	-0.6%	-$1.32K	0.04%	82
2024 Q1	$247K	Buy	+1,375	New	+$237K	0.04%	82
2018 Q4	–	Sell	-525	Closed	-$50K	–	78
2018 Q3	$50K	Buy	525 +47	+10%	+$4.46K	0.03%	117
2018 Q2	$44K	Buy	+478	New	+$46.7K	0.03%	93

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Iron Gate Global Advisors's ABBV Position: Q1 2026 in Review

Iron Gate Global Advisors increased its AbbVie (ABBV) stake by 4.4% in Q1 2026, buying an estimated $14K and bringing the position to 1,493 shares worth $325K. The position accounts for 0.03% of the portfolio, ranked #73.

Iron Gate Global Advisors first reported a position in ABBV in Q2 2018 and has held it in 10 quarters since. The position peaked at $328K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Iron Gate Global Advisors held 1,493 shares of AbbVie worth $325K as of Q1 2026.
Iron Gate Global Advisors bought 63 AbbVie shares in Q1 2026, an estimated $14K.
AbbVie made up 0.03% of Iron Gate Global Advisors's portfolio in Q1 2026, its #73 holding.
Iron Gate Global Advisors first reported a position in AbbVie in Q2 2018 and has held it in 10 quarters since.
Iron Gate Global Advisors's AbbVie position peaked at $328K in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Iron Gate Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.